Chad Fugere is an accomplished finance professional with extensive experience in investor relations and research analysis. Currently serving as Vice President of Investor Relations at Ascendis Pharma since August 2025, Chad previously held similar roles at Xenon Pharmaceuticals Inc. and Seagen, where responsibilities included strategic communication with investors. Chad’s career began in research analysis, with positions at Wells Capital Management and Wachovia Capital Markets, demonstrating a strong foundation in finance and investment strategies. Educational credentials include an MBA in Finance from the UMN Carlson School of Management and a BA in Economics from the University of South Florida.
This person is not in any teams
This person is not in any offices